RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma
Authors
Keywords
chemotherapeutics, clathrin-dependent endocytosis, drug-resistance, glutathione-conjugate transport, neuroblastoma, p53, RLIP76
Journal
PHARMACEUTICAL RESEARCH
Volume 34, Issue 8, Pages 1673-1682
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1007/s11095-017-2154-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in emerging drugs for the treatment of neuroblastoma
- (2017) Pablo Berlanga et al. EXPERT OPINION ON EMERGING DRUGS
- Epidermal growth factor receptor is overexpressed in neuroblastoma tissues and cells
- (2016) Chao Zheng et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Dinutuximab
- (2016) Cady Ploessl et al. ANNALS OF PHARMACOTHERAPY
- A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers
- (2016) MoonSun Jung et al. CANCER RESEARCH
- Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database
- (2016) Daniel A. Morgenstern et al. EUROPEAN JOURNAL OF CANCER
- HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
- (2016) Omid Tavana et al. NATURE MEDICINE
- A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma
- (2015) Qi Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Hsf1 Is Required for the Nuclear Translocation of p53 Tumor Suppressor
- (2015) Qiang Li et al. NEOPLASIA
- Chemotherapy-Induced Apoptosis in a Transgenic Model of Neuroblastoma Proceeds Through p53 Induction
- (2015) Louis Chesler et al. NEOPLASIA
- RalBP1 Is Necessary for Metastasis of Human Cancer Cell Lines
- (2015) Zhong Wu et al. NEOPLASIA
- Structure and function of RLIP76 (RalBP1): an intersection point between Ras and Rho signalling
- (2014) Helen R. Mott et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma
- (2014) Jiao Zhang et al. CANCER LETTERS
- RLIP76 Blockade by siRNA Inhibits Proliferation, Enhances Apoptosis, and Suppresses Invasion in HT29 Colon Cancer Cells
- (2014) Yi Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
- (2014) Y Shi et al. CELL DEATH AND DIFFERENTIATION
- Inhibitors of endocytosis prevent Wnt/Wingless signalling by reducing the level of basal -catenin/Armadillo
- (2014) M. Gagliardi et al. JOURNAL OF CELL SCIENCE
- Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells
- (2014) Kun Yao et al. TUMOR BIOLOGY
- RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis
- (2013) Qi Wang et al. CARCINOGENESIS
- Kinase Inhibitors: Adverse Effects Related to the Endocrine System
- (2013) Maya B. Lodish JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells
- (2013) Qi Wang et al. JOURNAL OF NEURO-ONCOLOGY
- The Structure of the RLIP76 RhoGAP-Ral Binding Domain Dyad: Fixed Position of the Domains Leads to Dual Engagement of Small G Proteins at the Membrane
- (2013) Karthik V. Rajasekar et al. STRUCTURE
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse
- (2012) Nathan Mollberg et al. CANCER BIOLOGY & THERAPY
- RALBP1/RLIP76 Depletion in Mice Suppresses Tumor Growth by Inhibiting Tumor Neovascularization
- (2012) S. Lee et al. CANCER RESEARCH
- RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer
- (2012) Kathryn Leake et al. PLoS One
- Regulation of the EGF Transcriptional Response by Endocytic Sorting
- (2012) B. Brankatschk et al. Science Signaling
- Deubiquitinases as a Signaling Target of Oxidative Stress
- (2012) Xiomaris M. Cotto-Rios et al. Cell Reports
- Targeting p53-Null Neuroblastomas through RLIP76
- (2011) J. Singhal et al. Cancer Prevention Research
- Activation and Involvement of Ral GTPases in Colorectal Cancer
- (2011) T. D. Martin et al. CANCER RESEARCH
- p53 regulation by ubiquitin
- (2011) Christopher L. Brooks et al. FEBS LETTERS
- Glutathione-Conjugate Transport by RLIP76 Is Required for Clathrin-Dependent Endocytosis and Chemical Carcinogenesis
- (2011) S. S. Singhal et al. MOLECULAR CANCER THERAPEUTICS
- MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
- (2011) L D Gamble et al. ONCOGENE
- Incidence of Pediatric Horner Syndrome and the Risk of Neuroblastoma
- (2010) Stephen J. Smith ARCHIVES OF OPHTHALMOLOGY
- RLIP76: A versatile transporter and an emerging target for cancer therapy
- (2010) Rit Vatsyayan et al. BIOCHEMICAL PHARMACOLOGY
- Mechanisms of 4-Hydroxy-2-nonenal Induced Pro- and Anti-Apoptotic Signaling
- (2010) Pankaj Chaudhary et al. BIOCHEMISTRY
- Making sense of ubiquitin ligases that regulate p53
- (2010) Abhinav K. Jain et al. CANCER BIOLOGY & THERAPY
- Primary pancreatic neuroblastoma: an unusual tumor in infancy
- (2010) Hari R. Kumar et al. JOURNAL OF PEDIATRIC SURGERY
- Mortality and morbidity of patients with neuroblastoma who survived for more than 10 years after treatment—Niigata Tumor Board Study
- (2010) Masayuki Kubota et al. JOURNAL OF PEDIATRIC SURGERY
- Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosis
- (2009) Sharad S. Singhal et al. CANCER LETTERS
- RLIP76: A Target for Kidney Cancer Therapy
- (2009) S. S. Singhal et al. CANCER RESEARCH
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- A Central Role of RLIP76 in Regulation of Glycemic Control
- (2009) S. Awasthi et al. DIABETES
- Role of RLIP76 in doxorubicin resistance in lung cancer (Review)
- (2009) Singhal INTERNATIONAL JOURNAL OF ONCOLOGY
- Endocytosis and signalling: intertwining molecular networks
- (2009) Alexander Sorkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Regression of prostate cancer xenografts by RLIP76 depletion
- (2008) Sharad S. Singhal et al. BIOCHEMICAL PHARMACOLOGY
- RLIP76: A novel glutathione-conjugate and multi-drug transporter
- (2008) Sharad S. Singhal et al. BIOCHEMICAL PHARMACOLOGY
- RLIP76 and Cancer
- (2008) S. Awasthi et al. CLINICAL CANCER RESEARCH
- Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76
- (2008) Sharad S. Singhal et al. FEBS LETTERS
- Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death
- (2008) Yogesh C. Awasthi et al. FREE RADICAL BIOLOGY AND MEDICINE
- RLIP76 in Defense of Radiation Poisoning
- (2008) Jyotsana Singhal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hsf-1 and POB1 Induce Drug Sensitivity and Apoptosis by Inhibiting Ralbp1
- (2008) Sharad S. Singhal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started